VIP拮抗剂
|
|
|
- CAS号:
- 125093-93-8
- 英文名:
- H-LYS-PRO-ARG-ARG-PRO-TYR-THR-ASP-ASN-TYR-THR-ARG-LEU-ARG-LYS-GLN-MET-ALA-VAL-LYS-LYS-TYR-LEU-ASN-SER-ILE-LEU-ASN-NH2
- 英文别名:
- VIPi;VIP ANTAGONIST;Vip-ne hybrid antag;KPRRPYTDNYTRLRKQMAVKKYLNSILN-NH2;Lys-Pro-Arg-arg-Pro-Tyr-vip(7-28);(VIP-neurotensin) hybrid antagonist;VASOACTIVE INTESTINAL PEPTIDE ANTAGONIST;(LYS1 PRO2 5 ARG3 4 TYR6)-VASOACTIVE &;(lys1,pro2,5,arg3,4,tyr6)-vasoactive*intestinal P;Lysyl-prolyl-arginyl-arginyl-prolyl-tyrosyl-vip(7-28)
- 中文名:
- VIP拮抗剂
- 中文别名:
- 血管活性肠肽VIP?ANTAGONIST
- CBNumber:
- CB9168677
- 分子式:
- C154H257N49O40S
- 分子量:
- 3467.06
- MOL File:
- 125093-93-8.mol
|
|
|
VIP拮抗剂化学性质
-
RTECS号:
-
YW8000000
-
|
-
储存条件:
-
−20°C
-
|
-
序列:
-
H-Lys-Pro-Arg-Arg-Pro-Tyr-Thr-Asp-Asn-Tyr-Thr-Arg-Leu-Arg-Lys-Gln-Met-Ala-Val-Lys-Lys-Tyr-Leu-Asn-Ser-Ile-Leu-Asn-NH2
-
|
VIP拮抗剂性质、用途与生产工艺
多肽
VIP拮抗剂是由28个氨基酸组成的多肽，是一种有效的外源性血管活性肠肽(VIP)拮抗剂多肽。
参考质量标准
外观:白色粉末
纯度(HPLC) ≥98.0%
醋酸根含量≤12.0%
水分含量≤8.0%
肽含量≥80.0%
内毒素≤50EU/mg
氨基酸组成分析≤±10%
VIP拮抗剂
上下游产品信息
上游原料
下游产品
125093-93-8, VIP拮抗剂 相关搜索:
醋酸阿肽地尔 THR-ARG-LEU-ARG-LYS-GLN-MET-ALA-VAL-LYS-LYS-TYR-LEU-ASN-SER-ILE-LEU-ASN-NH2 VASOACTIVEINTESTINALPEPTIDE(10-28),HUMAN,PORCINE,RAT HIS-SER-ASP-ALA-VAL-PHE-THR-ASP-ASN-TYR-THR-ARG VIP(3-28)(HUMAN,BOVINE,PORCINE,RAT) VIP(4-28)(HUMAN,BOVINE,PORCINE,RAT) (Β-ASP3)-VIP (PYR16)-VIP(16-28)(HUMAN,BOVINE,PORCINE,RAT) (LYS1?,ARG1?,LEU2?)-VIP(1-7)-GRF(8-27) BIOTINYL-VIP (P-CHLORO-D-PHE6,LEU17)-VIP(HUMAN,BOVINE,PORCINE,RAT) (D-PHE2)-VIP(HUMAN,BOVINE,PORCINE,RAT) VIP(GUINEAPIG) PHE-THR-ASP-ASN-TYR-THR-ARG-LEU-ARG-LYS-GLN-MET-ALA-VAL-LYS-LYS-TYR-LEU-ASN-SER-ILE-LEU-ASN-NH2 HEXANOYL-(ALA1?,LYS2??2?)-VIP TYR-THR-ARG-LEU-ARG-LYS-GLN-MET-ALA-VAL-LYS-LYS-TYR-LEU-ASN-SER-ILE-LEU-ASN-NH2:YTRLRKQMAVKKYLNSILN-NH2 VIPSULFOXIDE(HUMAN,BOVINE,PORCINE,RAT) ACETYL-(D-PHE2,LYS1?,ARG1?,LEU2?)-VIP(1-7)-GRF(8-27)
- 目录肽
- 目录多肽
- C154H257N49O40S
- 血管活性肠肽VIP?ANTAGONIST
- 125093-93-8
- L-Aspartamide, L-lysyl-L-prolyl-L-arginyl-L-arginyl-L-prolyl-L-tyrosyl-L-threonyl-L-α-aspartyl-L-asparaginyl-L-tyrosyl-L-threonyl-L-arginyl-L-leucyl-L-arginyl-L-lysyl-L-glutaminyl-L-methionyl-L-alanyl-L-valyl-L-lysyl-L-lysyl-L-tyrosyl-L-leucyl-L-asparaginyl-L-seryl-L-isoleucyl-L-leucyl-
- VIPi
- Vip-ne hybrid antag
- Vasoactive intestinal octacosapeptide (pig), 1-L-lysine-2-L-proline-3-L-arginine-4-L-arginine-5-L-proline-6-L-tyrosine-
- VIP Antagonist, VIPi, [Lys1, Pro2,5, Arg3,4, Tyr6]-VIP
- [Lys1, Pro2,5, Arg3,4, Tyr6]-Vasoactive Intestinal Peptide human, porcine, rat
- (VIP-neurotensin) hybrid antagonist
- (LYS1 PRO2 5 ARG3 4 TYR6)-VASOACTIVE &
- (lys1,pro2,5,arg3,4,tyr6)-vasoactive*intestinal P
- VIP ANTAGONIST
- VASOACTIVE INTESTINAL PEPTIDE ANTAGONIST
- Lysyl-prolyl-arginyl-arginyl-prolyl-tyrosyl-vip(7-28)
- Lys-Pro-Arg-arg-Pro-Tyr-vip(7-28)
- LYS-PRO-ARG-ARG-PRO-TYR-THR-ASP-ASN-TYR-THR-ARG-LEU-ARG-LYS-GLN-MET-ALA-VAL-LYS-LYS-TYR-LEU-ASN-SER-ILE-LEU-ASN-NH2
- KPRRPYTDNYTRLRKQMAVKKYLNSILN-NH2
- H-LYS-PRO-ARG-ARG-PRO-TYR-THR-ASP-ASN-TYR-THR-ARG-LEU-ARG-LYS-GLN-MET-ALA-VAL-LYS-LYS-TYR-LEU-ASN-SER-ILE-LEU-ASN-NH2